New MRI scan could reveal hidden brain tumors
NCT ID NCT07272616
First seen Jan 11, 2026 · Last updated Jun 20, 2026 · Updated 24 times
Summary
This study tests a new MRI sequence that aims to make brain tumors (metastases) more visible after contrast injection. Researchers will compare the new method to standard MRI in 100 adults with known or suspected brain tumors. The goal is to see if the new scan finds more or smaller tumors without increasing contrast dose or scan time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Karolinska University Hospital
RECRUITINGStockholm, Solna, 1171 76, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Novel Gadolinium-Weighted MRI Sequence
What this could lead to
If successful, this new MRI method could help doctors find more and smaller brain tumors, leading to earlier and more accurate diagnosis.
What could go wrong
This is a small, early-phase study with only 100 participants. The new sequence may not consistently outperform standard MRI, and results may not apply to all patients or scanners.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.